{
  "trial_id": "NCT00040196",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "stable clinical response to L-DOPA and DAergic agents",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "early or mild-to-moderate PD (Hoehn & Yahr scale < 3)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "non-demented, non-depressed, with parkinsonian symptoms and signs primarily akineto-rigid",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "mild or moderate tremor (UPDRS tremor ratings 1 or 2 in the right upper limb)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "familial history of PD",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "marked resting tremor (UPDRS scale > 3 in the right upper limb)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "progressive neurological disorders other than PD",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a stable clinical response to L-DOPA and DAergic agents, is in an early or mild-to-moderate stage of PD, and does not have dementia or depression. However, the patient's resting tremor status is unknown.",
  "_meta": {
    "topic_id": "41",
    "trial_id": "NCT00040196",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}